Quasispecies as a matter of fact: Viruses and beyond

Virus Research

Volumn 162, Issue 1-2, 2011, Pages 203-215

  Ojosnegros, Samuel ^a   Perales, Celia ^b,c   Mas, Antonio ^d   Domingo, Esteban ^b,c  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b CSIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d University of Castilla La Mancha   (Spain)

Author keywords

Bacterial communities; Cancer cell heterogeneity; Group selection; Mutation; Population dynamics; Prion conformation; RNA virus

Indexed keywords

DNA; PYRIMIDINE DERIVATIVE; RIBAVIRIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; CANCER CELL; CELL CULTURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FOOT AND MOUTH DISEASE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEPATITIS C; HUMAN; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA VIRUS; VIRUS GENOME; VIRUS MUTANT; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; BACTERIA; BIOLOGICAL EVOLUTION; DRUG RESISTANCE, VIRAL; GENOME, VIRAL; HUMANS; MICROBIAL CONSORTIA; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; PRIONS; PROTEIN CONFORMATION; QUANTUM THEORY; RNA VIRUSES; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS DISEASES; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); RNA VIRUSES;

EID: 81555214151     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.09.018     Document Type: Review

References (215)

1. Agudo R., Ferrer-Orta C., Arias A., de la Higuera I., Perales C., Perez-Luque R., Verdaguer N., Domingo E. A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. PLos Pathog. 2010, 6(8):e1001072.
2. Ali A., Li H., Schneider W.L., Sherman D.J., Gray S., Smith D., Roossinck M.J. Analysis of genetic bottlenecks during horizontal transmission of Cucumber mosaic virus. J. Virol. 2006, 80(17):8345-8350.
3. Alper T., Cramp W.A., Haig D.A., Clarke M.C. Does the agent of scrapie replicate without nucleic acid?. Nature 1967, 214(5090):764-766.
4. Anderson J.P., Daifuku R., Loeb L.A. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 2004, 58:183-205.
5. Arias A., Arnold J.J., Sierra M., Smidansky E.D., Domingo E., Cameron C.E. Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J. Virol. 2008, 82(24):12346-12355.
6. Barria M.A., Mukherjee A., Gonzalez-Romero D., Morales R., Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLos Pathog. 2009, 5(5):e1000421.
7. Batschelet E., Domingo E., Weissmann C. The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene 1976, 1(1):27-32.
8. Bernacki J.P., Murphy R.M. Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies. Biophys. J. 2009, 96(7):2871-2887.
9. Betancourt M., Fereres A., Fraile A., Garcia-Arenal F. Estimation of the effective number of founders that initiate an infection after aphid transmission of a multipartite plant virus. J. Virol. 2008, 82(24):12416-12421.
10. Bielas J.H., Loeb K.R., Rubin B.P., True L.D., Loeb L.A. Human cancers express a mutator phenotype. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(48):18238-18242.
11. Bolton D.C., McKinley M.P., Prusiner S.B. Identification of a protein that purifies with the scrapie prion. Science 1982, 218(4579):1309-1311.
12. Boveri T. Zur Frage der Entstehung Maligner Tumoren 1914, Verlag, Jena. G. Disher (Ed.).
13. Briones C., Domingo E. Minority report: hidden memory genomes in HIV-1 quasispecies and possible clinical implications. AIDS Rev. 2008, 10(2):93-109.
14. Brumer Y., Michor F., Shakhnovich E.I. Genetic instability and the quasispecies model. J. Theor. Biol. 2006, 241(2):216-222.
15. Caldwell D.E., Costerton J.W. Are bacterial biofilms constrained to Darwin's concept of evolution through natural selection?. Microbiologia 1996, 12(3):347-358.
16. Carrillo C., Borca M., Moore D.M., Morgan D.O., Sobrino F. In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J. Gen. Virol. 1998, 79(Pt 7):1699-1706.
17. Castilla J., Morales R., Saa P., Barria M., Gambetti P., Soto C. Cell-free propagation of prion strains. EMBO J. 2008, 27(19):2557-2566.
18. Castilla J., Saa P., Hetz C., Soto C. In vitro generation of infectious scrapie prions. Cell 2005, 121(2):195-206.
19. Castro C., Arnold J.J., Cameron C.E. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res. 2005, 107(2):141-149.
20. Codoner F.M., Daros J.A., Sole R.V., Elena S.F. The fittest versus the flattest: experimental confirmation of the quasispecies effect with subviral pathogens. PLos Pathog. 2006, 2(12):e136.
21. Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel J.C., Dasgupta M., Marrie T.J. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987, 41:435-464.
22. Costerton J.W., Geesey G.G., Cheng K.J. How bacteria stick. Sci. Am. 1978, 238(1):86-95.
23. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284(5418):1318-1322.
24. Crowder S., Kirkegaard K. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat. Genet. 2005, 37(7):701-709.
25. Chao L. Fitness of RNA virus decreased by Muller's ratchet. Nature 1990, 348(6300):454-455.
26. Chin L., Hahn W.C., Getz G., Meyerson M. Making sense of cancer genomic data. Genes Dev. 2011, 25(6):534-555.
27. Chumakov K.M., Powers L.B., Noonan K.E., Roninson I.B., Levenbook I.S. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(1):199-203.
28. de la Torre J.C., Davila M., Sobrino F., Ortin J., Domingo E. Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology 1985, 145(1):24-35.
29. de la Torre J.C., Holland J.J. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 1990, 64(12):6278-6281.
30. De Paepe M., Taddei F. Viruses' life history: towards a mechanistic basis of a trade-off between survival and reproduction among phages. PLos Biol. 2006, 4(7):e193.
31. Deisboeck T.S., Couzin I.D. Collective behavior in cancer cell populations. Bioessays 2009, 31(2):190-197.
32. Delgado-Eckert E., Ojosnegros S., Beerenwinkel N. The evolution of virulence in RNA viruses under a competition-colonization trade-off. Bull. Math. Biol. 2011, 73(8):1881-1908.
33. Denison M.R., Graham R.L., Donaldson E.F., Eckerle L.D., Baric R.S. Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biol. 2011, 8(2):270-279.
34. Djikeng A., Spiro D. Advancing full length genome sequencing for human RNA viral pathogens. Future Virol. 2009, 4(1):47-53.
35. Domingo E. RNA virus evolution and the control of viral disease. Prog. Drug Res. 1989, 33:93-133.
36. Domingo E. Quasispecies: concepts and implications for virology. Curr. Top. Microbiol. Immunol. 2006, 299.
37. Virus entry into error catastrophe as a new antiviral strategy. Virus Res. 2005, 107:115-228.
38. Domingo E., Biebricher C., Eigen M., Holland J.J. Quasispecies and RNA Virus Evolution: Principles and Consequences 2001, Landes Bioscience, Austin.
39. Domingo E., Davila M., Ortin J. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 1980, 11(3-4):333-346.
40. Domingo E., Escarmis C., Baranowski E., Ruiz-Jarabo C.M., Carrillo E., Nunez J.I., Sobrino F. Evolution of foot-and-mouth disease virus. Virus Res. 2003, 91(1):47-63.
41. Domingo E., Escarmís C., Menéndez-Arias L., Perales C., Herrera M., Novella I.S., Holland J.J. Viral quasispecies: dynamics, interactions and pathogenesis. Origin and Evolution of Viruses 2008, 87-118. Elsevier. E. Domingo, C. Parrish, J.J. Holland (Eds.).
42. Domingo E., Flavell R.A., Weissmann C. In vitro site-directed mutagenesis: generation and properties of an infectious extracistronic mutant of bacteriophage Qβ Gene 1976, 1(1):3-25.
43. Domingo E., Gomez J. Quasispecies and its impact on viral hepatitis. Virus Res. 2007, 127:131-150.
44. Domingo E., Holland J.J. High error rates population equilibrium, and evolution of RNA replication systems. RNA Genetics 1988, vol. III:3-36. CRC Press, Boca Raton, FL.
45. Domingo E., Holland J.J. Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents. Genet. Eng. 1992, 14:13-31.
46. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 1997, 51:151-178.
47. Domingo E., Holland J.J., Biebricher C., Eigen M. Quasispecies: the concept and the word. Molecular Evolution of the Viruses 1995, 171-180. Cambridge University Press, Cambridge. A. Gibbs, C. Calisher, F. García-Arenal (Eds.).
48. Domingo E., Martin V., Perales C., Grande-Perez A., Garcia-Arriaza J., Arias A. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 2006, 299:51-82.
49. Domingo E., Sabo D., Taniguchi T., Weissmann C. Nucleotide sequence heterogeneity of an RNA phage population. Cell 1978, 13(4):735-744.
50. Domingo E., Wain-Hobson S. The 30th anniversary of quasispecies. Meeting on 'Quasispecies: past, present and future'. EMBO Rep. 2009, 10(5):444-448.
51. Drake J.W., Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13910-13913.
52. Eckerle L.D., Becker M.M., Halpin R.A., Li K., Venter E., Lu X., Scherbakova S., Graham R.L., Baric R.S., Stockwell T.B., Spiro D.J., Denison M.R. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLos Pathog. 2010, 6(5):e1000896.
53. Eckerle L.D., Lu X., Sperry S.M., Choi L., Denison M.R. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 2007, 81(22):12135-12144.
54. Eigen M. Self-organization of matter and the evolution of biological macromolecules. Naturwissenschaften 1971, 58:465-523.
55. Eigen M. Steps Towards Life 1992, Oxford University Press.
56. Eigen M. Natural selection: a phase transition?. Biophys. Chem. 2000, 85:101-123.
57. Eigen M. Error catastrophe and antiviral strategy. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(21):13374-13376.
58. Eigen M., Biebricher C.K. Sequence space and quasispecies distribution. RNA Genetics 1988, vol. 3:211-245. CRC Press, Boca Raton, FL.
59. Eigen M., Schuster P. The hypercycle. A principle of natural self-organization 1979, Springer, Berlin.
60. Eriksson N., Pachter L., Mitsuya Y., Rhee S.Y., Wang C., Gharizadeh B., Ronaghi M., Shafer R.W., Beerenwinkel N. Viral population estimation using pyrosequencing. PLos Comput. Biol. 2008, 4(4):e1000074.
61. Escarmís C., Dávila M., Charpentier N., Bracho A., Moya A., Domingo E. Genetic lesions associated with Muller's ratchet in an RNA virus. J. Mol. Biol. 1996, 264:255-267.
62. Escarmís C., Dávila M., Domingo E. Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J. Mol. Biol. 1999, 285:495-505.
63. Escarmís C., Gómez-Mariano G., Dávila M., Lázaro E., Domingo E. Resistance to extinction of low fitness virus subjected to plaque-to-plaque transfers: diversification by mutation clustering. J. Mol. Biol. 2002, 315(4):647-661.
64. Escarmís C., Lazaro E., Arias A., Domingo E. Repeated bottleneck transfers can lead to non-cytocidal forms of a cytopathic virus: implications for viral extinction. J. Mol. Biol. 2008, 376(2):367-379.
65. Escarmís C., Lázaro E., Manrubia S.C. Population bottlenecks in quasispecies dynamics. Curr. Top. Microbiol. Immunol. 2006, 299:141-170.
66. Escarmís C., Perales C., Domingo E. Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing. J. Virol. 2009, 83(13):6748-6756.
67. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrieri A., Purcell R.H., Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000, 288(5464):339-344.
68. Figlerowicz M., Alejska M., Kurzynska-Kokorniak A., Figlerowicz M. Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections. Med. Res. Rev. 2003, 23(4):488-518.
69. Foster K.R. The sociobiology of molecular systems. Nat. Rev. Genet. 2011, 12(3):193-203.
70. Fox E.J., Loeb L.A. Lethal mutagenesis: targeting the mutator phenotype in cancer. Semin. Cancer Biol. 2010, 20(5):353-359.
71. Foy B.D., Myles K.M., Pierro D.J., Sanchez-Vargas I., Uhlirova M., Jindra M., Beaty B.J., Olson K.E. Development of a new Sindbis virus transducing system and its characterization in three Culicine mosquitoes and two Lepidopteran species. Insect Mol. Biol. 2004, 13(1):89-100.
72. Froissart R., Doumayrou J., Vuillaume F., Alizon S., Michalakis Y. The virulence-transmission trade-off in vector-borne plant viruses: a review of (non-)existing studies. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2010, 365(1548):1907-1918.
73. Fuqua W.C., Winans S.C., Greenberg E.P. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 1994, 176(2):269-275.
74. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., Rahman N., Stratton M.R. A census of human cancer genes. Nat. Rev. Cancer 2004, 4(3):177-183.
75. Garcia-Arriaza J., Domingo E., Briones C. Characterization of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications. Virus Res. 2007, 129(2):123-134.
76. Garcia-Arriaza J., Manrubia S.C., Toja M., Domingo E., Escarmis C. Evolutionary transition toward defective RNAs that are infectious by complementation. J. Virol. 2004, 78(21):11678-11685.
77. Garcia-Arriaza J., Ojosnegros S., Davila M., Domingo E., Escarmis C. Dynamics of mutation and recombination in a replicating population of complementing, defective viral genomes. J. Mol. Biol. 2006, 360(3):558-572.
78. Gelbart W.M., Knobler C.M. Virology. Pressurized viruses. Science 2009, 323(5922):1682-1683.
79. Ghaemmaghami S., Ahn M., Lessard P., Giles K., Legname G., DeArmond S.J., Prusiner S.B. Continuous quinacrine treatment results in the formation of drug-resistant prions. PLos Pathog. 2009, 5(11):e1000673.
80. Gonzalez-Garcia I., Sole R.V., Costa J. Metapopulation dynamics and spatial heterogeneity in cancer. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(20):13085-13089.
81. González-López C., Arias A., Pariente N., Gómez-Mariano G., Domingo E. Preextinction viral RNA can interfere with infectivity. J. Virol. 2004, 78(7):3319-3324.
82. González-López C., Gómez-Mariano G., Escarmís C., Domingo E. Invariant aphthovirus consensus nucleotide sequence in the transition to error catastrophe. Infect. Genet. Evol. 2005, 5:366-374.
83. Graci J.D., Cameron C.E. Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virol. 2008, 3(6):553-566.
84. Grande-Pérez A., Gómez-Mariano G., Lowenstein P.R., Domingo E. Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J. Virol. 2005, 79(16):10451-10459.
85. Grande-Pérez A., Lazaro E., Lowenstein P., Domingo E., Manrubia S.C. Suppression of viral infectivity through lethal defection. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(12):4448-4452.
86. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446(7132):153-158.
87. Griffith J.S. Self-replication and scrapie. Nature 1967, 215(5105):1043-1044.
88. Haaland R.E., Hawkins P.A., Salazar-Gonzalez J., Johnson A., Tichacek A., Karita E., Manigart O., Mulenga J., Keele B.F., Shaw G.M., Hahn B.H., Allen S.A., Derdeyn C.A., Hunter E. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLos Pathog. 2009, 5(1):e1000274.
89. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
90. Hansemann D.v. Ueber asymmetrische Zelltheilung in epithel Krebsen und deren biologische Bedeutung. Virchow's Arch. Pathol. Anat. 1890, 119:299.
91. Harris H. Enzyme polymorphisms in man. Proc. R. Soc. Lond. B: Biol. Sci. 1966, 164(995):298-310.
92. Herrera M., Garcia-Arriaza J., Pariente N., Escarmis C., Domingo E. Molecular basis for a lack of correlation between viral fitness and cell killing capacity. PLos Pathog. 2007, 3(4):e53.
93. Herrera M., Grande-Perez A., Perales C., Domingo E. Persistence of foot-and-mouth disease virus in cell culture revisited: implications for contingency in evolution. J. Gen. Virol. 2008, 89(Pt 1):232-244.
94. Holland J. Transitions in understanding of RNA viruses: an historical perspective. Curr. Top. Microbiol. Immunol. 2006, 299:371-401.
95. Holland J.J. Continuum of change in RNA virus genomes. Concepts in Viral Pathogenesis 1984, vols. 137-143. Springer-Verlag, New York.
96. Holland J.J. Defective viral genomes. Virology 1990, 151-165. Raven Press, New York. B.M. Fields, D.M. Knipe (Eds.).
97. Holland J.J., de la Torre J.C., Steinhauer D.A., Clarke D., Duarte E., Domingo E. Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions. J. Virol. 1989, 63(12):5030-5036.
98. Holland J.J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. Rapid evolution of RNA genomes. Science 1982, 215(4540):1577-1585.
99. Horiuchi K. Genetic studies of RNA phages. RNA Phages 1975, 29-50. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. N.D. Zinder (Ed.).
100. Hubby J.L., Lewontin R.C. A molecular approach to the study of genic heterozygosity in natural populations. I. The number of alleles at different loci in Drosophila pseudoobscura. Genetics 1966, 54(2):577-594.
101. Iranzo J., Manrubia S.C. Stochastic extinction of viral infectivity through the action of defectors. Europhys. Lett. 2009, 85:18001.
102. Iranzo, J., Perales, C., Domingo, E., Manrubia, S.C. Tempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach. Proc. Natl. Acad. Sci.USA, in press.
103. Jarosz D.F., Taipale M., Lindquist S. Protein homeostasis and the phenotypic manifestation of genetic diversity: principles and mechanisms. Annu. Rev. Genet. 2010, 44:189-216.
104. Lauring A.S., Andino R. Quasispecies theory and the behavior of RNA viruses. PLos Pathog. 2010, 6(7):e1001005.
105. Lauring A.S., Andino R. Exploring the fitness landscape of an RNA virus by using a universal barcode microarray. J. Virol. 2011, 85(8):3780-3791.
106. Le Guen B., Squadrito G., Nalpas B., Berthelot P., Pol S., Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 1997, 25(5):1250-1254.
107. Levi L.I., Gnadig N.F., Beaucourt S., McPherson M.J., Baron B., Arnold J.J., Vignuzzi M. Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLos Pathog. 2010, 6(10):e1001163.
108. Lewontin R.C., Hubby J.L. A molecular approach to the study of genic heterozygosity in natural populations. II. Amount of variation and degree of heterozygosity in natural populations of Drosophila pseudoobscura. Genetics 1966, 54(2):595-609.
109. Li H., Roossinck M.J. Genetic bottlenecks reduce population variation in an experimental RNA virus population. J. Virol. 2004, 78(19):10582-10587.
110. Li J., Browning S., Mahal S.P., Oelschlegel A.M., Weissmann C. Darwinian evolution of prions in cell culture. Science 2010, 327(5967):869-872.
111. Loeb L.A. A mutator phenotype in cancer. Cancer Res. 2001, 61(8):3230-3239.
112. Lopez-Labrador F.X., Ampurdanes S., Gimenez-Barcons M., Guilera M., Costa J., Jimenez de Anta M.T., Sanchez-Tapias J.M., Rodes J., Saiz J.C. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 1999, 29(3):897-903.
113. Luo J., Solimini N.L., Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009, 136(5):823-837.
114. Mahal S.P., Browning S., Li J., Suponitsky-Kroyter I., Weissmann C. Transfer of a prion strain to different hosts leads to emergence of strain variants. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(52):22653-22658.
115. Maley C.C., Forrest S. Exploring the relationship between neutral and selective mutations in cancer. Artif. Life 2000, 6(4):325-345.
116. Maley C.C., Galipeau P.C., Finley J.C., Wongsurawat V.J., Li X., Sanchez C.A., Paulson T.G., Blount P.L., Risques R.A., Rabinovitch P.S., Reid B.J. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 2006, 38(4):468-473.
117. Manrubia S.C., Escarmis C., Domingo E., Lazaro E. High mutation rates, bottlenecks, and robustness of RNA viral quasispecies. Gene 2005, 347(2):273-282.
118. Manrubia S.C., Garcia-Arriaza J., Domingo E., Escarmís C. Long-range transport and universality classes in in vitro viral infection spread. Europhys. Lett. 2006, 74:547-553.
119. Mardis E.R. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 2008, 9:387-402.
120. Maree A.F., Keulen W., Boucher C.A., De Boer R.J. Estimating relative fitness in viral competition experiments. J. Virol. 2000, 74(23):11067-11072.
121. Martinez-Picado J., Martinez M.A. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo. Virus Res. 2008, 134(1-2):104-123.
122. Mas A., Lopez-Galindez C., Cacho I., Gomez J., Martinez M.A. Unfinished stories on viral quasispecies and Darwinian views of evolution. J. Mol. Biol. 2010, 397(4):865-877.
123. Mas A., Ulloa E., Bruguera M., Furcic I., Garriga D., Fabregas S., Andreu D., Saiz J.C., Diez J. Hepatitis C virus population analysis of a single-source nosocomial outbreak reveals an inverse correlation between viral load and quasispecies complexity. J. Gen. Virol. 2004, 85(Pt 12):3619-3626.
124. Mateu M.G., Da Silva J.L., Rocha E., De Brum D.L., Alonso A., Enjuanes L., Domingo E., Barahona H. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology 1988, 167(1):113-124.
125. Mateu M.G., Martínez M.A., Rocha E., Andreu D., Parejo J., Giralt E., Sobrino F., Domingo E. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(15):5883-5887.
126. Mateu M.G., Rocha E., Vicente O., Vayreda F., Navalpotro C., Andreu D., Pedroso E., Giralt E., Enjuanes L., Domingo E. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 1987, 8(3):261-274.
127. Mayr E. The objects of selection. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(6):2091-2094.
128. Mellors J.W., Rinaldo C.R., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272(5265):1167-1170.
129. Merlo L.M., Pepper J.W., Reid B.J., Maley C.C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 2006, 6(12):924-935.
130. Miller M.B., Bassler B.L. Quorum sensing in bacteria. Annu. Rev. Microbiol. 2001, 55:165-199.
131. Mills D.R., Peterson R.L., Spiegelman S. An extracellular Darwinian experiment with a self-duplicating nucleic acid molecule. Proc. Natl. Acad. Sci. U. S. A. 1967, 58:217-224.
132. Mira A., Martin-Cuadrado A.B., D'Auria G., Rodriguez-Valera F. The bacterial pan-genome: a new paradigm in microbiology. Int. Microbiol. 2010, 13(2):45-57.
133. Morishima C., Polyak S.J., Ray R., Doherty M.C., Di Bisceglie A.M., Malet P.F., Bonkovsky H.L., Sullivan D.G., Gretch D.R., Rothman A.L., Koziel M.J., Lindsay K.L. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. J. Infect. Dis. 2006, 193(7):931-940.
134. Mueller Y.M., Do D.H., Altork S.R., Artlett C.M., Gracely E.J., Katsetos C.D., Legido A., Villinger F., Altman J.D., Brown C.R., Lewis M.G., Katsikis P.D. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J. Immunol. 2008, 180(1):350-360.
135. Muller H.J. The relation of recombination to mutational advance. Mutat. Res. 1964, 1:2-9.
136. Mullins J.I., Heath L., Hughes J.P., Kicha J., Styrchak S., Wong K.G., Rao U., Hansen A., Harris K.S., Laurent J.P., Li D., Simpson J.H., Essigmann J.M., Loeb L.A., Parkins J. Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461. PLos One 2011, 6(1):e15135.
137. Musso F. On the relation between the Eigen model and the asexual Wright-Fisher Model. Bull. Math. Biol. 2011, in press.
138. Nájera I., Holguín A., Quiñones-Mateu M.E., Muñoz-Fernández M.A., Nájera R., López-Galíndez C., Domingo E. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 1995, 69(1):23-31.
139. Nájera I., Richman D.D., Olivares I., Rojas J.M., Peinado M.A., Perucho M., Najera R., Lopez-Galindez C. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. AIDS Res. Hum. Retroviruses 1994, 10(11):1479-1488.
140. Nealson K.H., Hastings J.W. Bacterial bioluminescence: its control and ecological significance. Microbiol. Rev. 1979, 43(4):496-518.
141. Nicolson G.L. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 1987, 47(6):1473-1487.
142. Novella I.S. Contributions of vesicular stomatitis virus to the understanding of RNA virus evolution. Curr. Opin. Microbiol. 2003, 6(4):399-405.
143. Novella I.S., Duarte E.A., Elena S.F., Moya A., Domingo E., Holland J.J. Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(13):5841-5844.
144. Novella I.S., Reissig D.D., Wilke C.O. Density-dependent selection in vesicular stomatitis virus. J. Virol. 2004, 78(11):5799-5804.
145. Nowak M.A., Anderson R.M., McLean A.R., Wolfs T.F., Goudsmit J., May R.M. Antigenic diversity thresholds and the development of AIDS. Science 1991, 254(5034):963-969.
146. Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194(4260):23-28.
147. Ojosnegros S., Agudo R., Sierra M., Briones C., Sierra S., Gonzalez-Lopez C., Domingo E., Cristina J. Topology of evolving, mutagenized viral populations: quasispecies expansion, compression, and operation of negative selection. BMC Evol. Biol. 2008, 8:207.
148. Ojosnegros S., Beerenwinkel N., Antal T., Nowak M.A., Escarmis C., Domingo E. Competition-colonization dynamics in an RNA virus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(5):2108-2112.
149. Ojosnegros S., Beerenwinkel N., Domingo E. Competition-colonization dynamics: an ecology approach to quasispecies dynamics and virulence evolution in RNA viruses. Communicative Integr. Biol. 2010, 107(5):2108-2112.
150. Ojosnegros S., Garcia-Arriaza J., Escarmis C., Manrubia S.C., Perales C., Arias A., Mateu M.G., Domingo E. Viral genome segmentation can result from a trade-off between genetic content and particle stability. PLos Genet. 2011, 7(3):e1001344.
151. Page K.M., Nowak M.A. Unifying evolutionary dynamics. J. Theor. Biol. 2002, 219(1):93-98.
152. Park J.M., Munoz E., Deem M.W. Quasispecies theory for finite populations. Phys. Rev. E: Stat. Nonlin. Soft Matter Phys. 2010, 81(1 Pt 1):011902.
153. Perales C., Agudo R., Domingo E. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. PLos One 2009, 4(5):e5554.
154. Perales C., Agudo R., Manrubia S.C., Domingo E. Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus. J. Mol. Biol. 2011, 407(1):60-78.
155. Perales C., Agudo R., Tejero H., Manrubia S.C., Domingo E. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. PLos Pathog. 2009, 5(11):e1000658.
156. Perales, C., Henry, M., Domingo, E., Wain-Hobson, S., Vartanian, J.P. Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space. J. Virol. in press.
157. Perales C., Lorenzo-Redondo R., López-Galíndez C., Martínez M.A., Domingo E. Mutant spectra in virus behavior. Future Virol. 2010, 5(6):679-698.
158. Perales C., Martin V., Ruiz-Jarabo C.M., Domingo E. Monitoring sequence space as a test for the target of selection in viruses. J. Mol. Biol. 2005, 345(3):451-459.
159. Perales C., Mateo R., Mateu M.G., Domingo E. Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants. J. Mol. Biol. 2007, 369(4):985-1000.
160. Pfeiffer J.K., Kirkegaard K. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(12):7289-7294.
161. Pfeiffer J.K., Kirkegaard K. Increased fidelity reduces poliovirus fitness under selective pressure in mice. PLos Pathog. 2005, 1:102-110.
162. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216(4542):136-144.
163. Qin H., Shire N.J., Keenan E.D., Rouster S.D., Eyster M.E., Goedert J.J., Koziel M.J., Sherman K.E. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 2005, 105(2):533-541.
164. Queller D.C., Strassmann J.E. Eusociality. Curr. Biol. 2003, 13(22):R861-R863.
165. Quer J., Martell A., Rodriguez R., Bosch A., Jardi R., Buti M., Esteban J.I. The impact of rapid evolution of hepatitis viruses. Origin and Evolution of Viruses 2008, 303-350. Elsevier. E. Domingo, C. Parrish, J.J. Holland (Eds.).
166. Quer J., Esteban J.I., Cos J., Sauleda S., Ocana L., Martell M., Otero T., Cubero M., Palou E., Murillo P., Esteban R., Guardia J. Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infection. J. Virol. 2005, 79(24):15131-15141.
167. Quiñones-Mateu M.E., Arts E. Virus fitness: concept, quantification, and application to HIV population dynamics. Curr. Top. Microbiol. Immunol. 2006, 299:83-140.
168. Rice S.A., Tan C.H., Mikkelsen P.J., Kung V., Woo J., Tay M., Hauser A., McDougald D., Webb J.S., Kjelleberg S. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J. 2009, 3(3):271-282.
169. Rodriguez-Calvo T., Ojosnegros S., Sanz-Ramos M., Garcia-Arriaza J., Escarmis C., Domingo E., Sevilla N. New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines. PLos One 2010, 5(4):e10414.
170. Rothman A.L., Morishima C., Bonkovsky H.L., Polyak S.J., Ray R., Di Bisceglie A.M., Lindsay K.L., Malet P.F., Chang M., Gretch D.R., Sullivan D.G., Bhan A.K., Wright E.C., Koziel M.J. Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology 2005, 41(3):617-625.
171. Roux L., Simon A.E., Holland J.J. Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv. Virus Res. 1991, 40:181-211.
172. Ruiz-Jarabo C.M., Arias A., Baranowski E., Escarmís C., Domingo E. Memory in viral quasispecies. J. Virol. 2000, 74:3543-3547.
173. Rumbaugh K.P., Diggle S.P., Watters C.M., Ross-Gillespie A., Griffin A.S., West S.A. Quorum sensing and the social evolution of bacterial virulence. Curr. Biol. 2009, 19(4):341-345.
174. Saakian D.B., Biebricher C.K., Hu C.K. Phase diagram for the Eigen quasispecies theory with a truncated fitness landscape. Phys. Rev. E: Stat. Nonlin. Soft Matter Phys. 2009, 79(4 Pt 1):041905.
175. Saakian D.B., Hu C.K. Exact solution of the Eigen model with general fitness functions and degradation rates. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(13):4935-4939.
176. Saakian D.B., Munoz E., Hu C.K., Deem M.W. Quasispecies theory for multiple-peak fitness landscapes. Phys. Rev. E 2006, 73(4 Pt 1):041913.
177. Sacristan S., Fraile A., Malpica J.M., Garcia-Arenal F. An Analysis of host adaptation and its relationship with virulence in cucumber mosaic virus. Phytopathology 2005, 95(7):827-833.
178. Sanjuan R., Nebot M.R., Chirico N., Mansky L.M., Belshaw R. Viral mutation rates. J. Virol. 2010, 84(19):9733-9748.
179. Scholle F., Girard Y.A., Zhao Q., Higgs S., Mason P.W. trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 2004, 78(21):11605-11614.
180. Schuster P. Genotypes and phenotypes in the evolution of molecules. Evolutionary Genomics and Systems Biology 2010, 123-152. Wiley-Blackwell, Hoboken, New Jersey. G. Caetono-Anolles (Ed.).
181. Semler B.L., Holland J.J. Persistent vesicular stomatitis virus infection mediates base substitutions in viral RNA termini. J. Virol. 1979, 32(2):420-428.
182. Sevilla N., Ruiz-Jarabo C.M., Gomez-Mariano G., Baranowski E., Domingo E. An RNA virus can adapt to the multiplicity of infection. J. Gen. Virol. 1998, 79(Pt 12):2971-2980.
183. Sierra M., Airaksinen A., González-López C., Agudo R., Arias A., Domingo E. Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J. Virol. 2007, 81:2012-2024.
184. Smith D.R., Adams A.P., Kenney J.L., Wang E., Weaver S.C. Venezuelan equine encephalitis virus in the mosquito vector Aedes taeniorhynchus: infection initiated by a small number of susceptible epithelial cells and a population bottleneck. Virology 2008, 372(1):176-186.
185. Snijder B., Pelkmans L. Origins of regulated cell-to-cell variability. Nat. Rev. Mol. Cell Biol. 2011, 12(2):119-125.
186. Snijder B., Sacher R., Ramo P., Damm E.M., Liberali P., Pelkmans L. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature 2009, 461(7263):520-523.
187. Sobrino F., Dávila M., Ortín J., Domingo E. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 1983, 128:310-318.
188. Solé R.V., Deisboeck T.S. An error catastrophe in cancer?. J. Theor. Biol. 2004, 228(1):47-54.
189. Solé R.V., Rodriguez-Caso C., Deisboeck T.S., Saldana J. Cancer stem cells as the engine of unstable tumor progression. J. Theor. Biol. 2008, 253(4):629-637.
190. Spagnolo J.F., Rossignol E., Bullitt E., Kirkegaard K. Enzymatic and nonenzymatic functions of viral RNA-dependent RNA polymerases within oligomeric arrays. RNA 2010, 16(2):382-393.
191. Spencer, H. (1876) The Principles of Sociology, vol. 1. D. Appleton and company Eds.
192. Spiess E.B. Genes in Populations 1977, John Wiley & Sons, New York.
193. Spindler K.R., Horodyski F.M., Holland J.J. High multiplicities of infection favor rapid and random evolution of vesicular stomatitis virus. Virology 1982, 119(1):96-108.
194. Srikiatkhachorn A., Green S. Markers of dengue disease severity. Curr. Top. Microbiol. Immunol. 2010, 338:67-82.
195. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358(9276):135-138.
196. Stewart P.S., Franklin M.J. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 2008, 6(3):199-210.
197. Straub J.E., Thirumalai D. Toward a molecular theory of early and late events in monomer to amyloid fibril formation. Annu. Rev. Phys. Chem. 2011, 62:437-463.
198. Suspène R., Henry M., Guillot S., Wain-Hobson S., Vartanian J.P. Recovery of APOBEC3-edited human immunodeficiency virus G→A hypermutants by differential DNA denaturation PCR. J. Gen. Virol. 2005, 86(Pt 1):125-129.
199. Tannenbaum E., Sherley J.L., Shakhnovich E.I. Semiconservative quasispecies equations for polysomic genomes: the haploid case. J. Theor. Biol. 2006, 241(4):791-805.
200. Teng M.N., Oldstone M.B., de la Torre J.C. Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants. Virology 1996, 223(1):113-119.
201. Tuite M.F., Serio T.R. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat. Rev. Mol. Cell Biol. 2010, 11(12):823-833.
202. Turner P.E., Chao L. Prisoner's dilemma in an RNA virus. Nature 1999, 398(6726):441-443.
203. Turner P.E., Chao L. Escape from Prisoner's Dilemma in RNA phage phi6. Am. Nat. 2003, 161(3):497-505.
204. Tyedmers J., Madariaga M.L., Lindquist S. Prion switching in response to environmental stress. PLos Biol. 2008, 6(11):e294.
205. Valcarcel J., Ortin J. Phenotypic hiding: the carryover of mutations in RNA viruses as shown by detection of mar mutants in influenza virus. J. Virol. 1989, 63(9):4107-4109.
206. Vartanian J.P., Guetard D., Henry M., Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320(5873):230-233.
207. Verbinnen T., Van Marck H., Vandenbroucke I., Vijgen L., Claes M., Lin T.I., Simmen K., Neyts J., Fanning G., Lenz O. Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing. J. Virol. 2010, 84(21):11124-11133.
208. Vignuzzi M., Andino R. Biological implications of picornavirus fidelity mutants. The Picornaviruses 2010, 213-227. ASM Press, Washington, DC. E. Ehrenfeld, E. Domingo, R.P. Roos (Eds.).
209. Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 2006, 439:344-348.
210. Webster D.R., Hekele A.G., Lauring A.S., Fischer K.F., Li H., Andino R., DeRisi J.L. An enhanced single base extension technique for the analysis of complex viral populations. PLos One 2009, 4(10):e7453.
211. Whitaker R.J., Banfield J.F. Population genomics in natural microbial communities. Trends Ecol. Evol. 2006, 21(9):508-516.
212. Wilke C.O. Quasispecies theory in the context of population genetics. BMC Evol. Biol. 2005, 5:44.
213. Wilke C.O., Ronnewinkel C., Martinetz T. Dynamic fitness landscapes in molecular evolution. Phys. Rep. 2001, 349:395-446.
214. Wright C.F., Morelli M.J., Thebaud G., Knowles N.J., Herzyk P., Paton D.J., Haydon D.T., King D.P. Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing. J. Virol. 2011, 85(5):2266-2275.
215. Zagordi O., Klein R., Daumer M., Beerenwinkel N. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res. 2010, 38(21):7400-7409.